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The adherence of pseudomonal species was investigated by using a newly developed radiometric dacron fiber
microcolumn assay. Pseudomonas aeruginosa, P. stutzeri, and Xanthomonas maltophilia were more adherent
(-20%o) than P. pseudomaUlei, P. fluorescens, and P. cepacia (-10%o). Mucoid strains of P. aeruginosa were
consistently more adherent than nonmucoid strains (30% versus 20%k). Alginase was shown to inhibit the
adherence of mucoid but not nonmucoid P. aeruginosa. Monoclonal antibodies to alginate were also shown to
inhibit the adherence of mucoid but not nonmucoid P. aeruginosa. In addition, antibiotics active against P.
aeruginosa were shown to inhibit the adherence of both mucoid and nonmucoid strains. Furthermore,
synergism between dyadic combinations of monoclonal antibodies and antibiotic (ciprofloxacin), as well as
alginase and antibiotic, was also observed. These results indicate that bacterial alginate has an intrinsic role in
the adherence of mucoid P. aeruginosa and may have evolved not only for protection against dehydration in the
water and soil ecosystem of this bacterium, but also as a means of attaching to soil substrates in the same
ecosystem to enhance survival. They also suggest that synergistic combinations of antibiotics with alginase or
monoclonal antibodies to alginate may be of value in the therapy of some pseudomonal infections.
The gram-negative aerobic bacillus Pseudomonas aerugi-
nosa is an important pathogen in patients with malignancy
and other immunocompromising conditions (13, 25). In these
clinical situations, its ability to adhere to and colonize
intravenous catheters and other indwelling prosthetic de-
vices is a crucial factor in the pathogenesis of infection. The
mechanisms by which P. aeruginosa adheres are not com-
pletely understood, but the fimbriae of nonmucoid strains
have been implicated as important adhesins, and in mucoid
strains, the exopolysaccharide (alginate) may have a crucial
role as well, as demonstrated by experiments using biologi-
cal substrates such as tracheal epithelium and tracheobron-
chial mucin (10, 23, 30). These latter findings are of partic-
ular importance in cystic fibrosis, in which the emergence of
mucoid strains generally coincides with persistence of infec-
tion and inexorable progression of lung damage (16, 27). This
unique and fatal interaction between mucoid P. aeruginosa
and the airways of cystic fibrosis patients is explained on the
basis of a biological accident. In this regard, the natural
habitat of P. aeruginosa is subjected to periods of drying
out, and alginate may have evolved as a means of protecting
this bacterium from the hazards of dehydration. However,
we postulate that it may also have evolved to confer survival
advantage to this bacterium by enhancing its capacity for
adherence. We therefore compared the capacities of mucoid
and nonmucoid strains of P. aeruginosa to adhere to dacron
fiber, a biologically inert substrate (34), to determine
whether alginate has intrinsic adherence properties.
MATERIALS AND METHODS
Pseudomonas species and strains. The eight nonmucoid and
three mucoid P. aeruginosa clinical isolates used in this
study were obtained from Martyn Tilse and Theo Mollee,
Department of Microbiology, Mater Hospital (21). The five
* Corresponding author.
species ofPseudomonas, namely, P. cepacia, P. maltophilia
(now renamed Xanthomonas maltophilia), P. stutzeri, P.
psuedomallei, and P. fluorescens, were obtained from Lind-
say Sly, Curator of the Culture Collection, Department of
Microbiology, University of Queensland (22). In addition, a
mucoid clinical isolate of P. aeruginosa (strain 8050; Chan-
ning Laboratory) was obtained from the sputum of a patient
with cystic fibrosis by routine culture methods. The isogenic
nonmucoid revertant was derived by laboratory passage on
tryptic soy agar until a phenotypically nonmucoid isolate
was obtained. Strains were stored at -80°C in tryptic soy
broth with 10% glycerol and then plated for use. Prior to use,
and after plating in the adherence assay, visual inspection of
the colonial morphology of each strain was performed to
confirm that the mucoid and nonmucoid phenotypes were
maintained.
Stock cultures of P. cepacia were grown in sucrose
peptone agar, while the other Pseudomonas species were
grown in peptone yeast extract medium. They were stored in
aliquots in Protect Preservers (Sigma Pharmaceuticals, Syd-
ney, Australia) at -70°C (14). They were subcultured on
blood agar plates for each experiment. The purity of cultures
was determined by noting colony morphology on blood agar
plates and periodic checks on biochemical profiles.
The bacteria were harvested with a sterile loop and
washed twice in phosphate-buffered saline (PBS) by centrif-
ugation at 1,000 x g for 20 min. The bacteria were labelled
with [3H]thymidine as previously described (34). Bacteria
were inoculated into 100 ml of MacConkey broth (Oxoid,
Basingstoke, England) containing 0.25 ,uCi of [3H]thymidine
(Amersham) per ml. After 18 h of incubation at 37°C, the
labelled bacteria were harvested by centrifugation at 1,000 x
g for 20 min, washed twice in PBS, and resuspended in PBS
for the experiments. Bacterial concentrations were deter-
mined by McFarland nephelometry (3). Uptake of [3H]thy-
midine was correlated with CFU by plating on MacConkey's
medium; in 13 separate experiments, the mean ± standard
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deviation (SD) disintegrations per minute (dpm) and CFU
per microliter were 19,344 + 2,857 and 4.8 x 108+ 2.5 x
108, respectively.
Microassay for adherence of bacteria. The assay involved
measuring the adherence of bacteria to dacron fiber micro-
columns (34). These microcolumns were prepared by pack-
ing 10 mg of dacron fiber (Olympic General Products,
Queensland, Australia) into disposable 100-,u plastic pipette
tips (Stockwell Scientific, Monterey Park, Calif.) so as to
occupy the middle 1.5 cm of the 5-cm length of the pipette
tip. To each dacron fiber microcolumn was added 0.1 ml of
bacterial suspension; microcolumns were kept at 37°C and
high humidity in a humidified incubator. The contact time
was 60 min for most experiments.
The microcolumns were then placed into the inlet tubings
of a specially designed harvester apparatus (37). A vacuum
pressure of 25,000 kPa was applied for 1 min to remove the
nonadherent bacteria. One milliliter of normal saline was
added to each dacron fiber microcolumn to wash off nonad-
herent bacteria. Vacuum pressure of 25,000 kPa was further
applied for 1 min to remove excess washing solution. Each
fiber microcolumn was then removed from the pipette tip
and placed in a scintillation tube containing 2 ml of scintil-
lation fluid (Optiphase Hisage, FSA Lab Supplies). All
experiments were performed in triplicate. The dpm were
counted in an automatic scintillation counter. The percent
bacteria adhering to the fiber was calculated by the following
formula: (dpm of fiber column x 100)/total dpm added.
Preparation of alginase. Bacillus circulans was obtained
from the American Type Culture Collection, Rockville, Md.
(ATCC 15518), and grown in alginate-yeast extract medium
at 26°C with vigorous aeration (11). After 3 to 4 days, the
medium was centrifuged at 8,000 x g and 4°C for 20 min, and
the supernatant was removed and concentrated 10-fold with
Centriprep-10 (Amicon, Victoria, Australia). Alginase was
precipitated from the concentrate by adding ammonium
sulfate (70% saturation), and the precipitates were collected
by centrifugation at 20,000 x g for 30 min at 4°C. The
precipitates were dissolved in 10 mM Tris hydrochloride (pH
7.4) and dialyzed overnight against Tris hydrochloride.
This crude preparation of alginase was further purified by
chromatography in a DEAE-Sephacel column (2.5 by 20 cm;
Sigma, St. Louis, Mo.). The alginase was eluted with a Tris
buffer-NaCl gradient (0.05 to 0.5 M), and the fractions were
collected and dialyzed against distilled water overnight and
then lyophilized.
Specific activity of the alginase was quantitated by the
periodate-thiobarbiturate assay (41). Briefly, the 0.5-,ul en-
zyme was added to 0.5 ,ul of sodium alginate (2.5 mg/ml) at
room temperature. Samples of 50 ,ul were removed at 10-min
intervals for up to 60 min and added to 0.25 ,ul of 0.25 N
HI04 in 0.125 N H2SO4. After 20 min at room temperature
with shaking, 0.5 ml of 2% sodium arsenite in 5 N HCl was
added and the mixture was allowed to stand for 2 min; then
2 ml of 0.3% thiobarbituric acid (pH 2.0) was added and the
mixture was stirred and heated to 100°C for 10 min. After the
mixture had cooled, the optical density was measured at 549
nm in an LKB spectrophotometer. One unit of alginase
activity was defined as the amount of enzyme required to
liberate 1 nM f-formylpyruvate per min per ml (0.01 ,uM
produces an increase in optical density of 0.29). The protein
concentration was determined by the method of Lowry (20)
so that alginase activity could be expressed as units per
milligram of protein. The concentration of enzyme was
adjusted to 500 U/ml for the experiments.
MIC. The MIC of each antibiotic was determined by
standard broth dilution tests in Mueller-Hinton broth, using
inocula of approximately 105 to 106 CFU/ml. Inocula were
prepared following culture in broth for 4 to 6 h and adjusted
to a 0.5 McFarland standard. A further 1:2,000 dilution with
broth was made, and then 1.0 ml of each final dilution of
organisms was added to each tube of a serial dilution of an
antibiotic. The MIC of the antibiotics was defined as the
lowest concentration that inhibited visible growth in the
broth mixture after 16 to 20 h of incubation at 35°C.
Preparation ofMAbs. Monoclonal antibodies (MAbs) were
prepared in mice against Pseudomonas alginate by standard
methods. Briefly, animals were immunized with whole bac-
teria (108 CFU per animal) at multiple times. Spleen cells
were recovered 3 days after the final immunization and fused
with myeloma cell lines (SP/2 for 8/5/31.3 and P3X for
M/K/16.2) by means of polyethylene glycol. Supernatants
were screened for antibody in an enzyme-linked immunosor-
bent assay (ELISA) (5), and contents of positive wells were
cloned twice by limiting dilution. Wells were rescreened by
ELISA, and the hybridoma cells were transformed to pro-
gressively larger cell culture volumes to produce sufficient
amounts for antibody testing in an opsonophagocytic assay
(2). The antibodies were then classified as opsonic or nonop-
sonic on the basis of this in vitro activity. They were stored
as culture supernatants at -70°C until use. The two selected
for use in these experiments are designated 8/5/31.3 and
MIK/16.2. The former mediates opsonic killing of mucoid P.
aeruginosa in the presence of human neutrophils and com-
plement, while the latter fails to mediate opsonic killing and
binds to a different epitope on the alginate antigen, although
both MAbs are of the immunoglobulin G2b (IgG2b) class.
These characteristics of the two MAbs have been previously
documented (28, 29, 32). Dilutions of 1:10 of these MAb
culture supernatants were used in these experiments.
Statistical analysis. The Student t test was used for statis-
tical analysis of data.
RESULTS
Adherence of pseudomonal species. We first compared a
nonmucoid strain of P. aeruginosa with other pseudomonal
species for adherence properties. The results (Fig. 1) show
that P. aeruginosa, X. maltophilia, and P. stutzeri gave
adherence values in the 20% range, while P. psuedomallei,
P. fluorescens, and P. cepacia gave values in the 10% range.
We next compared three mucoid and eight nonmucoid
isolates of P. aeruginosa (Fig. 2) and found that mucoid
strains were significantly more adherent than nonmucoid
strains (30.6% ± 0.6% versus 19.3% + 2.3%; P < 0.001). We
further compared paired mucoid and nonmucoid isolates (of
strain 8050) and confirmed that the mucoid pair was consis-
tently more adherent than the nonmucoid revertant (Table
1).
Effect of antibiotics on adherence. We next investigated the
capacities of 16 antibiotics at a concentration of 10 p,g/ml to
inhibit the adherence of mucoid and nonmucoid strains of P.
aeruginosa. For the nonmucoid strain, it was found (Fig. 3)
that ciprofloxacin, imipenem, piperacillin, ceftazidime, cef-
pirome, and aztreonam caused significant inhibition of ad-
herence whereas the other 10 antibiotics did not. There was
some correlation with the MIC, except for azithromycin and
amikacin, which showed low MICs but no adherence-inhib-
itory activity.
For the mucoid strain of P. aeruginosa, significant adher-
ence inhibition was observed in the presence of aztreonam,
ciprofloxacin, imipenem, and timentin, while the other 12
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FIG. 1. Adherence of pseudomonal species to dacron fiber microcolumns. [3H]thymidine-labelled bacteria (3 x 109/ml) were incubated for
37°C for various times in the microcolumns, extracted by vacuum, and washed, and the radioactivity of the fibers was determined in a
scintillation counter. Results are expressed as percent adherence (mean + SD) of three separate experiments, each performed in triplicate.
P. aeruginosa
I-
non-mucold strains mucoid strains
FIG. 2. Comparison of adherence of mucoid and nonmucoid P.
aeruginosa. Radiolabelled bacteria (3 x 109/ml) were placed into
microcolumns for 60 min and washed, and the radioactivity in the
fibers was determined. Results are shown as the means + SDs of
three separate experiments, each performed in triplicate. The mu-
coid strains were significantly more adherent than the nonmucoid
strains (30.6% ± 0.6% versus 19.3% ± 2.3%; P < 0.001).
antibiotics were nonactive in this regard (Fig. 3). There was
some correlation of adherence-inhibitory activity with MIC,
except for ticarcillin and piperacillin, which showed low
MICs but no adherence-inhibitory activity.
Effect of alginase on adherence. We then studied the effects
of alginase on adherence. The results (Fig. 4) show that
alginase caused significant inhibition of adherence of the
mucoid but not the nonmucoid strain of P. aeruginosa. The
adherence inhibition of the mucoid strain was greater than
that caused by ciprofloxacin. In addition, the adherence-
inhibitory effects of alginase and ciprofloxacin were syner-
TABLE 1. Adherence of paired mucoid and nonmucoid isolates
of P. aeruginosa 8050a
Adherence (% [mean + SD])
Expt
Mucoid Nonmucoid
1 23.1 ± 3.7 14.2 ± 1.6
2 27.0 ± 5.6 13.4 + 1.7
3 27.5 ± 3.5 15.4 ± 2.7
a Each experiment was performed in triplicate, and the results are ex-
pressed as percent adherence (mean + SD). Altogether, three experiments
were performed, each with a separate batch of bacteria grown in culture on a
different day.
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FIG. 3. Effects of antibiotics on the adherence of P. aeruguiosa:
comparison with MIC. Radiolabelled bacteria (3 x 109/ml) were
incubated with 10-pg/ml concentrations of various antibiotics at
37°C for 30 min, placed into dacron fiber microcolumns for a further
60 min, and then extracted by vacuum and washed. The dacron
fibers were removed for determinations of residual radioactivity. 0,
adherence; 0, MIC. Results are shown as means ± SDs of 3
separate experiments, each performed in triplicate. Cip, ciproflox-
acin; Imi, imipenem; Pip, piperacillin; Cfz, ceftazidime; Cfp, cef-
pirome; Azl, azlocillin; Azt, aztreonam; Ami, amikacin; Tob, to-
bramycin; Azi, azithromycin; Tim, timentin; Cfz, cefotaxime; Cft,
ceftriaxone; Ery, erythromycin; Gen, gentamicin; Tic, ticarcillin. *,
P < 0.001.
gistic in the mucoid strain. Heat inactivation of alginase
completely abrogated its adherence-inhibitory properties.
Effect of MAb against alginate. In the final set of experi-
ments, we studied two MAbs raised against alginate antigen,
one opsonic and one nonopsonic, for their effects on adher-
ence. Again, it was shown (Fig. 5) that both these MAbs
inhibited adherence in the mucoid but not in the nonmucoid
strain ofP. aeruginosa and that the inhibitory effect could be
eliminated by heat inactivation of the MAbs. Moreover,
synergism between the MAbs and ciprofloxacin could be
demonstrated in the mucoid strain.
DISCUSSION
There is good experimental evidence to suggest that
alginate is an important mechanism for adherence of mucoid
strains of P. aeruginosa in relation to biological substrates
(10, 23, 30), but whether it has intrinsic properties for
a)
C Cipro Aig lAig Alg+ IAIg+
Cipro Cipro
FIG. 4. Effect of alginase on adherence of P. aeruginosa. Radio-
labelled bacteria (3 x 109/ml) were incubated with 500 U of alginase
per ml for 30 min at 37°C, placed into dacron fiber microcolumns for
another 60 min, and then vacuum extracted and washed. The dacron
fibers were removed for determination of residual radioactivity.
IAIg, heat inactivated; EC3D, synergism. Results are shown as means
SDs of three separate experiments, each performed in triplicate.
*,P < 0.001.
adherence is unknown. The alginate produced by mucoid P.
aeruginosa is an acetylated polymer of D-mannuronic and
L-guluronic acids, arranged either in homogenous fashion or
as mixed blocks (12). It is similar in structure to the alginate
of marine algae, except that it is acetylated and lacks
guluronic acid blocks (35). The biological role of
pseudomonal alginate is thought to be one of protecting this
aquatic bacterium from dehydration. Therefore the propen-
sity of these bacteria to colonize the airways of patients with
cystic fibrosis (17, 28) may be regarded as a biological
accident. This colonizing propensity mediated by alginate
can be explained either on the basis of the anti-phagocytic
and immunosuppressive properties of alginate as a means of
evading host defenses (4, 24, 26, 31, 33, 36) or on the basis of
the increased adherence capacity provided by alginate (10,
23, 30), although both mechanisms are more likely to be
complementary rather than mutually exclusive. We now
provide further support for the concept of alginate as a major
adhesin of mucoid P. aeruginosa. First, mucoid strains
consistently demonstrated significantly greater adherence
than nonmucoid strains. Second, the adherence capacity of
mucoid strains could be reduced by treatment with alginase,
an enzyme which specifically degrades alginate. Third,
monoclonal antibodies raised against alginate, whether op-
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FIG. 5. Effect of MAbs to alginate on adherence of P. aerugi-
nosa. Radiolabelled bacteria (3 x 109/ml) were incubated with MAb
(1:10 dilution) and/or ciprofloxacin (10 ,ug/ml) for 30 min at 37°C,
placed into dacron fiber microcolumns for another 60 min, and then
vacuum extracted and washed. The dacron fibers were removed for
determination of residual radioactivity. ED, synergism; IMab, heat
inactivated. Results are shown as means + SDs of three separate
experiments, each performed in triplicate. *, P < 0.001.
than those that act on bacterial protein or nucleic acid
metabolism (e.g., 5-fluorocytosine). However, in our current
study of both mucoid and nonmucoid strains of P. aerugi-
nosa, no such correlation could be made between the
adherence-inhibitory effects of an antibiotic and its mode of
action. Thus ciprofloxacin, an inhibitor of DNA replication,
was as potent an inhibitor of bacterial adherence as any of
the cell wall-active beta-lactam drugs. Considerable varia-
tion was noted in the adherence-inhibitory effects of the
different beta-lactam drugs tested. The aminoglycosides
gentamicin, tobramycin, and amikacin, which block RNA-
induced protein synthesis, did not have any inhibitory effects
on adherence, but the isolates tested were resistant to these
drugs for which MICs were >32 ,g/ml. Although some
correlation may be deduced between the MIC of the organ-
ism and the adherence-inhibitory effect for the drugs tested,
this is not very convincing, perhaps because the MIC itself is
not a particularly good measure of antibiotic susceptibility.
Interference with adherence mechanisms has been sug-
gested as a plausible way in which infections can be con-
trolled or prevented. A variety of substances, including
antibody (18, 38, 42), phagocytic cells (7, 40), milk (9, 17),
and antibiotics (1, 6, 8, 15, 19, 39), have been shown to
interfere with microbial adherence. Data from our experi-
ments indicate that antibiotics can also interfere with the
adherence of both mucoid and nonmucoid P. aeruginosa to
plastic surfaces. Of greater interest was the finding that for
mucoid P. aeruginosa, combinations of antibiotic-alginase
and antibiotic-MAb were also synergistic. These findings
were specific because denaturation of these proteins by heat
abolished their adherence-inhibitory properties. These re-
sults suggest that combinations of these compounds may
have some value in clinical situations in which mucoid P.
aeruginosa is particularly troublesome.
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sonic or nonopsonic, could be shown to significantly reduce
adherence. Fourth, heat denaturation of both alginase and
MAb resulted in loss of inhibitory capacity, suggesting that
the action of these molecules is dependent on their structural
integrity. These findings lend credence to the data from
epithelial cell and tracheobronchial mucin experiments indi-
cating that alginate has an importanl role in adherence of
mucoid P. aeruginosa which is intrinsic and not wholly
dependent on interaction with biological tissues. In this
regard, the biologic roles of alginate may include the en-
hanced attachment of P. aeruginosa to soil substrates in its
natural habitat and, together with its hydration properties,
may confer survival advantage to this bacterium in soil and
water ecosystems.
Many previous studies have shown that antibiotics in
concentrations lower than those required to inhibit growth
can inhibit adherence (35). It is generally assumed that this
inhibition of adherence is related to antibiotic effects on the
bacterial cell wall or membrane. We have previously shown
(39) that antifungal drugs that act on the fungal cell wall (e.g.,
amphotericin B) have a greater adherence-inhibitory effect
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